Association of Biotechnology Led Enterprises

News

Biocon Operating Revenue at Rs 4296 Cr

“With a resilient foundation, differentiated portfolio, and clear strategy, we are well positioned to sustain growth and deliver long-term value to our stakeholders,” said Dr Kiran Mazumdar-Shaw, Chairperson, Biocon Group.

Dec 10, 2025

By : Team ABLE

Biocon to Integrate Biocon Biologics to Create a Unified Global Biopharmaceutical Leader

This integration enables Biocon to harness the combined strengths of its generics and biosimilars businesses across 120+ countries. Biocon Biologics ranks among the Top 5 global biosimilar players by revenue, with 10 commercialized products across key markets, while Biocon’s generics business offers over 90 products.

Dec 06, 2025

By : Team ABLE

Global biosimilars market to reach Rs 73 billion in 2030 predicts Fortune Business Insights

A biosimilar is a biological medicine highly similar to another already approved biological medicine (the 'reference medicine'). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines.

Dec 05, 2025

By : Team ABLE

Lupin Quarterly Results

Lupin is a global pharmaceutical company from India, advancing healthcare through innovation, research and accessible medicines globally.

Nov 30, 2025

By : Team ABLE

TruAlt Sumitomo to collaborate to produce Compressed Biomethane Gas in India

Japan based Sumitomo Corporation has agreed to acquire a portion of the shares of Bengaluru-based TruAlt Gas Pvt Ltd, a subsidiary of TruAlt BioEnergy and enter into a strategic collaboration with the Indian company.

Nov 29, 2025

By : Team ABLE